Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse ; day:7 ; month:6 ; year:2016 ; pages:1-11
Journal of neurology ; (7.6.2016), 1-11
- Urheber
-
Jongen, Peter Joseph
- Beteiligte Personen und Organisationen
-
Stavrakaki, Ioanna
Voet, Bernard
Hoogervorst, Erwin
Munster, Erik van
Linssen, Wim H.
Sinnige, Ludovicus G.
Verhagen, Wim I.
Visser, Leo H.
Kruijk, Ruud van der
Verheul, Freek
Boringa, Jan
Heerings, Marco
Gladdines, Werner
Lönnqvist, Fredrik
Gaillard, Pieter
SpringerLink (Online service)
- DOI
-
10.1007/s00415-016-8183-3
- URN
-
urn:nbn:de:1111-2016060821768
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jongen, Peter Joseph
- Stavrakaki, Ioanna
- Voet, Bernard
- Hoogervorst, Erwin
- Munster, Erik van
- Linssen, Wim H.
- Sinnige, Ludovicus G.
- Verhagen, Wim I.
- Visser, Leo H.
- Kruijk, Ruud van der
- Verheul, Freek
- Boringa, Jan
- Heerings, Marco
- Gladdines, Werner
- Lönnqvist, Fredrik
- Gaillard, Pieter
- SpringerLink (Online service)
Ähnliche Objekte (12)
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial
High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study
High-dose methylprednisolone pulse therapy for treatment of refractory intestinal involvement caused by Henoch–Schönlein purpura: a case report
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial
High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study
High-dose methylprednisolone pulse therapy for treatment of refractory intestinal involvement caused by Henoch–Schönlein purpura: a case report
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial
High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study
High-dose methylprednisolone pulse therapy for treatment of refractory intestinal involvement caused by Henoch–Schönlein purpura: a case report
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study